MRC and DfID contribution to jointly funded rapid response strategic award.

点击翻译按钮获取中文摘要

Details of the Strategic Award made Professor Adrian Hill Oxford University Ebola Phase 1 trial Accelerated Clinical Evaluation of Monovalent vectored Ebola vaccineAn outbreak of Ebola in West Africa has spread from Guinea to several countries and presents a continuing threat. WHO have declared this an international public health emergency. The current proposal aims to test the most suitable potential vaccine candidate for Ebola in humans for the first time, in the UK and West Africa, in parallel with collaborators at NIH, to determine its safety and immunogenicity. Successful completion of these trials in 2014 would provide WHO with the option of deploying this vaccine early in 2015.